Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Infection ; 51(2): 407-416, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35922704

RESUMO

PURPOSE: The clinical course of COVID-19 has been complicated by secondary infections, including bacterial and fungal infections. The rapid rise in the incidence of invasive mucormycosis in these patients is very much concerning. COVID-19-associated mucormycosis was detected in huge numbers during the second wave of the COVID-19 pandemic in India, with several predisposing factors indicated in its pathogenesis. This study aimed to evaluate the epidemiology, predisposing factor, cumulative mortality and factors affecting outcomes among the coronavirus disease COVID-19-associated mucormycosis (CAM). METHODS: A multicenter retrospective study across three tertiary health care centers in Southern part of India was conducted during April-June 2021. RESULTS: Among the 217 cases of CAM, mucormycosis affecting the nasal sinuses was the commonest, affecting 95 (44%) of the patients, orbital extension seen in 84 (38%), pulmonary (n = 25, 12%), gastrointestinal (n = 6, 3%), isolated cerebral (n = 2) and disseminated mucormycosis (n = 2). Diabetes mellitus, high-dose systemic steroids were the most common underlying disease among CAM patients. The mucormycosis-associated case-fatality at 6 weeks was 14%, cerebral or GI or disseminated mucormycosis had 9 times higher risk of death compared to other locations. Extensive surgical debridement along with sequential antifungal drug treatment improved the survival in mucormycosis patients. CONCLUSION: Judicious and appropriate management of the predisposing factor and factors affecting mortality associated with CAM with multi-disciplinary approach and timely surgical and medical management can be much helpful in achieving a successful outcome.


Assuntos
COVID-19 , Mucormicose , Humanos , Mucormicose/epidemiologia , Mucormicose/terapia , Estudos Retrospectivos , Pandemias , COVID-19/complicações , COVID-19/epidemiologia , COVID-19/terapia , Índia/epidemiologia , Causalidade , Antifúngicos/uso terapêutico
2.
Int Surg ; 100(6): 1069-71, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26414829

RESUMO

Splenic artery pseudoaneurysm is a rare entity. Clinical diagnosis is challenging because presentation is often varied. It can range from an incidental finding to hemodynamic collapse from sudden rupture and bleeding. The most common cause of this condition is pancreatitis. We report an unusual case of a young man not known to have pancreatitis who presented with hematemesis with normal esophagogastroduodenoscopy. Imaging modalities did not lead to a definitive diagnosis, and he underwent emergency laparotomy with surgical ligation of splenic artery pseudoaneurysm for hemodynamic instability, without a definitive preoperative diagnosis.


Assuntos
Falso Aneurisma/diagnóstico , Falso Aneurisma/cirurgia , Artéria Esplênica , Colangiopancreatografia por Ressonância Magnética , Diagnóstico Diferencial , Endoscopia do Sistema Digestório , Humanos , Masculino , Cisto Pancreático/diagnóstico , Tomografia Computadorizada por Raios X , Adulto Jovem
3.
Asian Pac J Trop Med ; 5(4): 329-30, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22449529

RESUMO

Melioidosis, a disease of public health importance in Southeast Asia and Northern Australia, of late has shown an increasing trend in India, particularly Southern India. We describe a case of a 39-year-old diabetic patient with left elbow septic arthritis, multiple liver, splenic abscesses, pneumonia, pleural effusion, followed by sepsis syndrome. Blood cultures and culture of the joint aspirate yielded pure growth of Burkholderia pseudomallei (B. pesudomallei), sensitive to carbapenem, co-trimoxazole and resistant to ceftazidime. The patient was successfully treated with imipenem- cilastin. He was discharged on co-trimoxazole to complete the 24 weeks course and follow-up has continued to date. The patient continues to remain asymptomatic. The case re-emphasizes the need to monitor the trend of B. pseudomallei in India, particularly the development of ceftazidime resistance, which incidentally is the drug of choice.


Assuntos
Antibacterianos/uso terapêutico , Ceftazidima/uso terapêutico , Melioidose/tratamento farmacológico , Adulto , Burkholderia pseudomallei , Farmacorresistência Bacteriana , Humanos , Índia , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...